tiprankstipranks
Trending News
More News >
Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4
Germany Market

Vicore Pharma Holding AB (6Y4) Cash flow

Compare
2 Followers

Vicore Pharma Holding AB Cash Flow

DE:6Y4's free cash flow for Q4 2024 was kr-51.17M. For the 2024 fiscal year, DE:6Y4's free cash flow was decreased by kr283.68M and operating cash flow was kr-51.17M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -164.95Mkr -249.58Mkr -299.92Mkr -265.17Mkr -119.94M
Investing Cash Flow
kr 149.04Mkr -144.46Mkr 74.00Mkr -7.00Mkr 4.00M
Financing Cash Flow
kr 834.06Mkr 470.86Mkr 187.04Mkr 318.18Mkr 176.97M
End Cash Position
kr 1.16Bkr 333.62Mkr 256.80Mkr 294.20Mkr 248.62M
Free Cash Flow
kr -164.95Mkr -448.62Mkr -302.92Mkr -265.17Mkr -122.94M
Currency in SEK

Vicore Pharma Holding AB Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis